JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials | JACC Specialty Journals | lystn | Audio Stories, Podcasts, Originals

JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials

Commentary by Corralea Kappel

2356 232

JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials29 days ago

02:46

Suggested Podcasts

Aao Baat Krte Hai!

Tamil Yeoja

FILM FRONTIER

Historias De Vida

Ladies, First

Fly-In Radio

Meri Kahani with Bhawana Somaaya

But Why: A Podcast for Curious Kids

Short History Of...

Motivational Lafz

Download the app

Get it on Google Play Available on the App Store

PRIVACY POLICY | TERMS AND CONDITIONS

lystn.fm © 2024.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS. | NX Digital FZ LLC & Tellyfonic Digital Media